intraductal papillary mucinous neoplasm
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The patients who underwent POPS using SpyGlass-DStm for preoperative assessment of suspected BD-IPMNs with MPD dilatation (> 5mm) by radiologic imaging modality between July 2018 and December 2021
Exclusion criteria
Exclusion criteria: Patients who are judged to be inappropriate for the principal investigator or coordinator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| main pancreatic duct involvement rate of brunch-duct intraductal papillary mutinous neoplasm with ductal dilatation more than 5mm | — |
Countries
Japan
Contacts
University of Toyama Third Department of Internal Medicine